Principal Investigator: Dr. Muhammad Saeed

Dr. Muhammad Saeed is an Associate Professor of Organic Chemistry whose research combines synthetic organic chemistry, medicinal chemistry, chemical biology, computational drug discovery, and advanced drug delivery to develop innovative solutions for cancer and infectious diseases. His research emphasizes translating fundamental molecular design into therapeutically relevant small molecules, targeted delivery systems, and functional biomaterials. He earned his Ph.D. in Organic Chemistry from the University of Tübingen, Germany, and subsequently completed postdoctoral research at the University of Iowa and the University of Nebraska Medical Center (UNMC), where he worked on molecular imaging, estrogen metabolism, and mechanisms of breast carcinogenesis. These experiences have shaped a multidisciplinary research program at the interface of chemistry and biomedicine. The Bioorganic & Medicinal Chemistry (BMC) group, envisioned and founded by Dr. Saeed, integrates organic synthesis, computational chemistry, molecular modeling, and biological evaluation to discover new therapeutic agents and smart drug delivery platforms. Current research interests include anticancer and antiviral drug discovery, endocrine-resistant breast cancer, peptide-based nanomaterials, stimuli-responsive drug delivery systems, and sustainable catalytic technologies. Dr. Saeed is committed to training the next generation of scientists through interdisciplinary research and international collaborations. His group's mission is to bridge fundamental chemistry with translational biomedical research, developing innovative and accessible technologies that advance human health.